jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 04, 2026

June. 04, 2026

jRCTs051260068

Study to Assess Beta Cell Mass in Diabetes Using GLP-1 Receptor Targeted PET Imaging

GLP-1 Receptor Targeted PET Imaging Study for Diabetes

Murakami Takaaki

Kyoto University Graduate School of Medicine

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

+81-75-751-3560

tounaiei@kuhp.kyoto-u.ac.jp

Yoshida Hayao

Kyoto University Graduate School of Medicine

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

+81-75-751-3560

tounaiei@kuhp.kyoto-u.ac.jp

Recruiting

June. 04, 2026

20

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

diagnostic purpose

i. Individuals diagnosed with diabetes, as well as those clinically determined to be at high risk of developing diabetes.
ii. Individuals aged 15 years or older.

i. Severe hepatic or renal impairment (AST or ALT > 200 U/L; eGFR < 15 mL/min/1.73 m2)
ii. Currently using GLP-1-related products and unable to discontinue them
iii. Not suitable for, or has contraindications to, exenatide administration
iv. History of alcohol intolerance or severe intolerance to Tween 80 or metoclopramide
v. Any other condition deemed inappropriate for participation in this study at the discretion of the principal investigator or sub-investigator(s)

15age old over
No limit

Both

Diabetes

PET imaging using 18F

Diabetes

D003920

Pancreatic beta-cell mass

Insulin secretion capacity, blood glucose fluctuations

Kyoto University Certified Review Board
53 Shogoin-kawahara-cho, Sakyo-ku, Kyoto

+81-75-366-7618

ethcom@kuhp.kyoto-u.ac.jp
Approval

May. 11, 2026

No

none